Fundraising FoxImmuneoncia
2 known investors
Find your way into Immuneoncia
Sign up to see every warm intro you have to Immuneoncia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Immuneoncia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Immuneoncia develops immuno-oncology cancer therapeutics, including antibody drugs targeting PD-L1 and CD47, with a program targeting both CD47 and PD-L1 simultaneously. Based in South Korea, the company works to advance immune-based cancer treatments.
Investors · 2
Frequently asked questions
- What does Immuneoncia do?
- Immuneoncia develops immuno-oncology cancer therapeutics, including antibody drugs targeting PD-L1 and CD47, with a program targeting both CD47 and PD-L1 simultaneously. Based in South Korea, the company works to advance immune-based cancer treatments.
- Who are Immuneoncia's investors?
- Immuneoncia's investors include LB Investment, Premier Partners.